Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy
Status:
RECRUITING
Trial end date:
2027-12-10
Target enrollment:
Participant gender:
Summary
The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephropathy.